Xcout Intel
Alesta Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Alesta Therapeutics among biotechnology companies — ranked by similarity to what Alesta Therapeutics actually does, not by market-cap band.
Subscribe to see Alesta Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Alesta Therapeutics
Alesta Therapeutics is a clinical-stage biotechnology company based in Leiden, Netherlands, dedicated to developing novel oral small-molecule therapies targeting GCN2 for underserved rare diseases.
Alesta Therapeutics at a glance
Alesta Therapeutics is a biotechnology company headquartered in Netherlands. Its most recent funding round, Series A, raised $68M in January 2025. Xcout tracks 8 named people at Alesta Therapeutics, including Ilan Ganot (CEO).
Alesta Therapeutics leadership
- Ilan GanotCEO
- Benit MaruCMO
- Matthias Van WoenselCSO
- Jakub SwierczVP R&D
- John DulosSr. VP Translational&Pharmacology
- Rick DekkerVP, Finance
2 more named people on record for Alesta Therapeutics, with roles, board committees and tenure — see the full roster →
Alesta Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $68M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Alesta Therapeutics news
Top 12 Alesta Therapeutics competitors
Ranked by semantic similarity — how close each company is to Alesta Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Lisata Therapeutics is a clinical-stage pharmaceutical company headquartered in Basking Ridge, New Jersey, dedicated to developing advanced therapies to improve the treatment of various serious diseases.
Similar biotechnology company
Scenic Biotech is a biotechnology company headquartered in Amsterdam, Netherlands, that advances modifier therapy as an approach to treating genetic disorders by uncovering novel genome pathways.
Biotech
Artica Therapeutics is a Dutch biotechnology company specializing in drug discovery and the development of novel covalent small molecule therapies.
Similar biotechnology company
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Similar biotechnology company
AM-Pharma is a biopharmaceutical company based in Utrecht, the Netherlands, focused on developing proprietary recombinant human alkaline phosphatase therapeutics like ilofotase alfa for severe medical conditions.
Similar biotechnology company
Leal Therapeutics, Inc. is a biotechnology company headquartered in Worcester, Massachusetts, focused on pioneering first-in-class neuro-metabolic therapeutics to treat patients with severe brain and metabolic health disorders.
Similar biotechnology company
Galecto Biotech is a biotechnology company developing small-molecule inhibitors targeting galectin proteins and related pathways, with applications in fibrotic diseases and cancer. Its products are intended for patients and healthcare providers, particularly in areas with limited treatment options.
Similar biotechnology company
Aldena Therapeutics is a biotechnology company focused on transforming dermatology through novel siRNA-based treatments for skin conditions.
Biotech
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Similar biotechnology company
Altesa BioSciences is a clinical-stage pharmaceutical company headquartered in College Park, Georgia. The company is dedicated to improving the lives of individuals suffering from chronic lung diseases, including conditions such as COPD and asthma.
Similar biotechnology company
Cadenza Bio, Inc. is a privately held preclinical biotechnology company founded in 2022 and headquartered in Oklahoma City, dedicated to developing novel, non-steroidal, highly selective small-molecule therapies.
Similar biotechnology company
Centaurus Therapeutics is a clinical-stage biotechnology company that develops first-in-class small-molecule therapies targeting ceramides to treat cardio-kidney-metabolic (CKM) diseases. The company's lead oral asset, CNT2130, inhibits DES1 to reduce excess ceramide production and restore lipid balance for patients suffering from organ decline.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Alesta Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Alesta Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →